Enduring controversies in the management of hyperbilirubinemia in preterm neonates

  • Watchko J
  • Jeffrey Maisels M
  • 41

    Readers

    Mendeley users who have this article in their library.
  • 15

    Citations

    Citations of this article.

Abstract

Although it is generally believed that preterm infants are at greater risk for the development of bilirubin-associated brain damage than term infants, quantification of the magnitude of this risk has proven elusive, as has a consensus among experts on the level of total serum bilirubin at which therapy should be initiated. Two large randomized studies have been performed that shed some light on the risk hyperbilirubinemia poses for preterm neonates and both studies are reviewed. Additional study is needed to further clarify the risk posed by hyperbilirubinemia in premature neonates and to frame guidelines for phototherapy and exchange transfusion that are more evidence-based. © 2009 Elsevier Ltd. All rights reserved.

Author-supplied keywords

  • Bilirubin:albumin ratio
  • Exchange transfusion
  • Extremely low birthweight
  • Neurodevelopmental outcome
  • Phototherapy
  • Prematurity

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Authors

  • Jon F. Watchko

  • M. Jeffrey Maisels

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free